Related Experiment Video
Updated: Aug 21, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Michael S Levine1, Carlos Cepeda, Miriam A Hickey
1Mental Retardation Research Center, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. mlevine@mednet.ucla.edu
Abstract:
Genetic mouse models based on identification of genes that cause Huntington's and Parkinson's diseases have revolutionized understanding of the mechanistic pathophysiological progression of these disorders. These models allow the earliest manifestations of the diseases to be identified, and they display behavioral, neuropathological and electrophysiological deficits that can be followed over time in mechanistic and drug studies. An intriguing feature is that they do not reproduce the relatively selective and massive cell loss characterizing the human diseases. There is more information on Huntington's disease models because the disorder involves a single gene that was identified over ten years ago; genetic mutations causing Parkinson's disease are rare and were discovered more recently, and models of the disease have been generated only within the past few years.
Insights
Genetic mouse models offer insights into Huntington's and Parkinson's disease mechanisms. However, these models do not fully replicate the significant cell loss seen in human patients.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Genetic mouse models have advanced the study of neurodegenerative diseases like Huntington's and Parkinson's.
- These models enable early identification of disease manifestations and facilitate mechanistic and drug studies.
Purpose of the Study:
- To review the utility and limitations of genetic mouse models in understanding Huntington's and Parkinson's diseases.
- To highlight the differences between model phenotypes and human disease pathology.
Main Methods:
- Review of existing literature on genetic mouse models for Huntington's and Parkinson's disease.
- Comparative analysis of disease progression, cellular pathology, and behavioral deficits in models versus human patients.
Main Results:
- Genetic mouse models exhibit behavioral, neuropathological, and electrophysiological deficits relevant to Huntington's and Parkinson's disease.
- A key limitation is the failure of current models to replicate the massive, selective cell loss characteristic of human Huntington's and Parkinson's disease.
Conclusions:
- Genetic mouse models are valuable tools for studying early disease mechanisms and testing therapeutics for Huntington's and Parkinson's disease.
- Further development of models is needed to accurately recapitulate the full spectrum of human neuropathology, particularly cell loss.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Parkinson Disease ll: Pathophysiology
In-vitro Mutagenesis
Huntington Disease l: Introduction

